These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26999402)

  • 1. Carbamazepine-related antiepileptic drugs for the treatment of epilepsy - a comparative review.
    Gierbolini J; Giarratano M; Benbadis SR
    Expert Opin Pharmacother; 2016; 17(7):885-8. PubMed ID: 26999402
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.
    Banach M; Borowicz KK; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):639-48. PubMed ID: 25740561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests.
    Ley M; Principe A; Jiménez-Conde J; Rocamora R
    Epilepsy Res; 2015 Sep; 115():147-52. PubMed ID: 26220393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evidence for switching dibenzazepines in people with epilepsy.
    Watkins L; O'Dwyer M; Oak K; Lawthom C; Maguire M; Thomas R; Shankar R
    Acta Neurol Scand; 2020 Aug; 142(2):121-130. PubMed ID: 32249420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
    Intravooth T; Staack AM; Juerges K; Stockinger J; Steinhoff BJ
    Epilepsy Res; 2018 Jul; 143():7-10. PubMed ID: 29631131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with eslicarbazepine in patients with hiponatremia due to carbamazepine and oxcarbacepine].
    Bermejo PE; Dorado R; Belarrinaga B
    Rev Neurol; 2015 Jul; 61(1):47-8. PubMed ID: 26108910
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.
    Ambrósio AF; Soares-Da-Silva P; Carvalho CM; Carvalho AP
    Neurochem Res; 2002 Feb; 27(1-2):121-30. PubMed ID: 11926264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
    Schmid E; Kuchukhidze G; Kirschner M; Leitinger M; Höfler J; Rohracher A; Kalss G; Wendling AS; Steinhoff BJ; Trinka E
    Acta Neurol Scand; 2017 Apr; 135(4):449-453. PubMed ID: 27444636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A proposal for a model to replace carbamazepine or oxcarbazepine by eslicarbazepine acetate in clinical practice].
    Poza-Aldea JJ
    Rev Neurol; 2016 Sep; 63(5):219-23. PubMed ID: 27569568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible precipitation of myoclonic seizures with oxcarbazepine.
    Kaddurah AK; Holmes GL
    Epilepsy Behav; 2006 Feb; 8(1):289-93. PubMed ID: 16356781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.
    Kay L; Willems LM; Zöllner JP; Reif PS; Klein KM; Rosenow F; Strzelczyk A
    Seizure; 2017 Apr; 47():81-82. PubMed ID: 28340402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
    Grant SM; Faulds D
    Drugs; 1992 Jun; 43(6):873-88. PubMed ID: 1379159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.
    Peltola J; Holtkamp M; Rocamora R; Ryvlin P; Sieradzan K; Villanueva V
    Epilepsy Behav; 2015 Sep; 50():46-9. PubMed ID: 26114438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
    Fong JK; Chan EL; Leung H; Chan I; Chang RS; Fong GC; Fung EL; Lui CH; Fung BB; Poon TL; Siu D; Wong HT; Yeung E; Yung AW; Zhu CX;
    Hong Kong Med J; 2017 Feb; 23(1):74-88. PubMed ID: 28184017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term effects of dibenzazepines on metabolic parameters: retrospective comparison of carbamazepine, oxcarbazepine and eslicarbazepine acetate in the real world].
    Ley M; Principe A; Rocamora R
    Rev Neurol; 2020 Jul; 71(2):54-60. PubMed ID: 32627160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia induced by antiepileptic drugs in patients with epilepsy.
    Lu X; Wang X
    Expert Opin Drug Saf; 2017 Jan; 16(1):77-87. PubMed ID: 27737595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug.
    Doeser A; Dickhof G; Reitze M; Uebachs M; Schaub C; Pires NM; Bonifácio MJ; Soares-da-Silva P; Beck H
    Brain; 2015 Feb; 138(Pt 2):371-87. PubMed ID: 25472797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.